3 results
Primary Objective* To describe the antitumour efficacy of LAN monotherapy plus BSC every 28 days, in terms of progression-free survival (PFS), measured by central review using Response Evaluation Criteria in Solid Tumours (RECIST) v1.1 criteria,…
This study is an extension of the European Multicenter Tics in Children Studies (EMTICS) Course study for which a separate study protocol exists; its aim is to verify the efficacy of GAS colonization treatment on tic symptoms in term of severity.…
Primary Objective:* To evaluate the effect of treatment with omecamtiv mecarbil (OM) compared with placebo on exercise capacity as determined by cardiopulmonary exercise testing (CPET) following 20 weeks of treatment with OM or placeboSecondary…